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Abstract
It has been recently hypothesized that many of the signals detected in genome-wide association studies (GWAS) to T2D and
other diseases, despite being observed to common variants, might in fact result from causal mutations that are rare. One
prediction of this hypothesis is that the allelic associations should be population-specific, as the causal mutations arose after
the migrations that established different populations around the world. We selected 19 common variants found to be
reproducibly associated to T2D risk in European populations and studied them in a large multiethnic case-control study
(6,142 cases and 7,403 controls) among men and women from 5 racial/ethnic groups (European Americans, African
Americans, Latinos, Japanese Americans, and Native Hawaiians). In analysis pooled across ethnic groups, the allelic
associations were in the same direction as the original report for all 19 variants, and 14 of the 19 were significantly
associated with risk. In summing the number of risk alleles for each individual, the per-allele associations were highly
statistically significant (P,10
24) and similar in all populations (odds ratios 1.09–1.12) except in Japanese Americans the
estimated effect per allele was larger than in the other populations (1.20; Phet=3.8610
24). We did not observe ethnic
differences in the distribution of risk that would explain the increased prevalence of type 2 diabetes in these groups as
compared to European Americans. The consistency of allelic associations in diverse racial/ethnic groups is not predicted
under the hypothesis of Goldstein regarding ‘‘synthetic associations’’ of rare mutations in T2D.
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Introduction
Multiple common risk alleles have been identified as reproduc-
ibly associated with risk of type 2 diabetes (T2D) [1–13]. With the
exception of the KCNQ1 locus which was identified in the Japanese
population [1,2], all of the well-replicated risk variants were first
identified in populations of Northern European ancestry [3–13].
T2D morbidity varies widely across racial/ethnic groups; the
prevalence is more than twice as high among African Americans,
Japanese Americans, Latinos and Native Hawaiians as European
Americans [14,15]. It is important to evaluate whether and how
genetic variation may contribute to health disparities between
populations. For example, genetic variation at 8q24 may
contribute to population differences in risk of prostate cancer
[16,17], and genetic variation at MYH9 contributes substantially
to the higher rates of kidney disease in African Americans [18].
It has recently been argued that single rare causal variants and/
or collections of multiple different rare variants on unrelated
haplotypes may create ‘‘synthetic associations’’ of common
variants with disease risk [19–21]. One prediction of this model
is that the associations with common variants will not be consistent
across populations (since many of the mutations will be young in
age, and post-date the migrations that led to the founding of
modern continental populations). Type 2 diabetes has been
specifically discussed as a possible case in which synthetic
associations might be operative, based on the lack of statistical
significance in very small studies that examined allelic associations
for T2D in multi-ethnic samples.
Testing the association of each validated risk allele for T2D in
multiple populations is an important step to determine (a) whether
these genetic markers can be used to better understand population
risk in non-European populations, (b) to measure their association
with racial/ethnic variation in disease risk, and (c) to test a
prediction of the Goldstein ‘‘common SNP, rare mutation’’
hypothesis [19–21].
To allow for comparability of estimates of genetic risk among
racial/ethnic groups requires large studies comprised of cases and
controls defined using identical criteria and sampled ideally from
the same study population. In the present study, we, as part of the
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risk alleles for T2D in European American, African American,
Latino, Japanese American, and Native Hawaiian T2D cases
(n=6,142) and controls (n=7,403) from the population-based
Multiethnic Cohort study (MEC). We also evaluated whether these
variants can be utilized to model the genetic risk of T2D in each
population and their association to disparities in risk.
Results
The age of the cases and controls ranged from 45 to 77 at
cohort entry, with the mean age of cases (mean 59.0 years) being
essentially the same as the controls (mean 58.8 years), and African
Americans being on average the oldest (mean 60.2 years) and
Native Hawaiians the youngest (mean 55.6 years). Compared to
controls, cases were heavier, more likely to be a current or former
smoker, less physically active and had fewer years of education
(Table 1). Compared to the other groups, the Japanese were leaner
(for cases and controls, men and women).
The established T2D risk SNPs were polymorphic (frequen-
cy.0.05) in all racial/ethnic groups (Figure 1), except for
rs10923931 (NOTCH2) in Japanese and Native Hawaiians and
rs7903146 (TCF7L2) in Japanese (Table 2). In European
populations these 19 SNPs have very modest odds ratios (1.1–
1.3 per copy of the risk allele), and required studies of more than
ten thousand cases and controls to reach genome-wide significance
[3–13,22]. Our sample sizes, although substantial, provided
limited power to detect these modest effects (Table S1; power to
achieve nominal significance (P=0.05) of 34%, 47%, 67%, 54%,
and 33%, in European Americans, African Americans, Latinos,
Japanese Americans, and Native Hawaiians, respectively).
We first assessed whether the ‘‘risk allele’’ of each SNP was
associated in the same direction (odds ratios.1) in each ethnic
group. Whereas the null hypothesis is that 50% of ‘‘risk’’ alleles
would trend in the same direction, we observed from 12 (63%;
P=0.18; binomial probability) in European Americans to 19
(100%; P=1.9610
26) in Japanese Americans. The number of
these associations that reached nominal significance (P,0.05)
ranged from 3 (P=0.067; binomial probability) in Native
Hawaiians to 10 (P=5.9610
29) in Japanese (Table 2). For the
majority of alleles with positive associations, odds ratios for
Author Summary
Single rare causal alleles and/or collections of multiple rare
alleles have been suggested to create ‘‘synthetic associa-
tions’’ with common variants in genome-wide association
studies (GWAS). This model predicts that associations with
common variants will not be consistent across popula-
tions. In this study, we examined 19 T2D variants for
association with T2D risk in 6,142 cases and 7,403 controls
from five racial/ethnic populations in the Multiethnic
Cohort (European Americans, African Americans, Latinos,
Japanese Americans, and Native Hawaiians). In racial/
ethnic pooled analysis, all 19 variants were associated with
T2D risk in the same direction as previous reports in
Europeans, and the sum total of risk variants was
significantly associated with T2D risk in each racial/ethnic
group. The consistent associations across populations do
not support the Goldstein hypothesis that rare causal
alleles underlie GWAS signals. We also did not find
evidence that these markers underlie racial/ethnic dispar-
ities in T2D prevalence. Large-scale GWAS and sequencing
studies in these populations are necessary in order to both
improve the current set of markers at these risk loci and
identify new risk variants for T2D that may be difficult, or
impossible, to detect in European populations.
Table 1. The descriptive characteristics of type 2 diabetes cases and controls in the MEC at baseline by racial/ethnic group and
sex.
Characteristic European Americans African Americans Latinos Japanese Americans Native Hawaiians
Cases Controls Cases Controls Cases Controls Cases Controls Cases Controls
Men
N 288 504 408 634 1,063 1,051 978 986 258 493
Age (yr, mean 6 SD) 57.668.1 57.568.0 62.667.9 61.967.9 59.766.9 59.766.9 59.068.2 59.168.2 55.567.0 55.667.0
BMI (kg/m
2, mean 6 SD) 29.464.7 25.163.1 28.964.5 26.263.8 28.464.2 26.263.3 26.964.0 24.563.1 31.064.8 28.065.2
Weight (lbs, mean 6 SD) 209638 180625 206637 187630 188631 174625 172630 156623 215638 194640
Former/current smoker (%) 77.7 60.1 75.7 73.5 72.4 63.3 72.3 67.8 70.9 66.1
Education (#12 years, %) 27.9 11.1 39.6 39.7 59.3 55.9 29.1 26.0 48.8 40.6
Physical activity (0 hrs / wk, %)
a 30.9 21.0 45.8 38.3 34.6 29.5 35.3 30.9 24.4 19.3
Women
N 245 502 669 835 1,157 1,133 758 775 318 490
Age (yr, mean 6 SD) 58.168.3 58.368.3 59.168.6 58.668.6 59.067.1 59.167.0 59.468.5 59.568.4 55.767.6 55.767.6
BMI (kg/m
2, mean 6 SD) 30.266.2 24.464.5 31.866.3 27.665.7 30.065.9 26.264.4 26.664.6 22.863.5 31.466.7 26.465.2
Weight (lbs, mean 6 SD) 179639 147628 191639 166635 170634 148626 145627 124621 186642 155633
Former or current smoker (%) 45.7 48.6 51.9 51.3 36.3 31.0 35.6 30.2 51.3 47.1
Education (#12 years, %) 30.2 20.9 37.1 30.5 74.9 68.5 34.7 31.9 51.4 46.0
Physical activity (0 hrs / wk, %)
a 55.1 44.2 64.6 58.6 66.8 59.7 64.3 61.9 50.3 37.1
aHours per week of vigorous activity of both work and sports.
doi:10.1371/journal.pgen.1001078.t001
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in each population, which provides support for their associations
and allele dosage effects (Table S2). In African Americans, results
were similar after adjustment for percent European ancestry
(Table S3). Adjustment for education, a proxy for socio-economic
status (SES) and European ancestry, did not influence the results
(Table S4) [23].
We next performed analyses that combined evidence for
association across the five ethnic groups. In this analysis the
power to achieve nominal significance for the allelic effects
reported previously was .80% for 18 out of 19 alleles (average
94%; Table S1). In this analysis all 19 (100%; P=1.9610
26,
binomial probability) variants were associated with risk in the same
direction as the initial report (odds ratios.1) and 14
(P=5.7610
215; binomial probability) with nominal statistical
significance (P,0.05). All 19 associations remained in the same
direction as previous reports (OR.1) and 13 of the variants were
significantly associated with T2D risk when the European
American subjects were excluded from the analysis. The
association of rs8050136 in FTO was attenuated by adjustment
for BMI (odds ratio (95% confidence interval), 1.06(1.00–1.11)
prior to adjustment; 1.02(0.96–1.08) after adjustment). Only 5 of
the 19 risk variants showed nominal evidence for heterogeneity in
the odds ratio across ethnic groups, and only one of these
(CDKAL1) was significant after correction for having performed 19
tests (PPARG, rs1801282, Phet=0.048; WFS1, rs10010131,
Phet=0.032; CDKAL1, rs7754840, Phet=6.2610
24; HHEX,
rs1111875, Phet=0.037; and, HNF1B, rs4430796, Phet=0.043;
Table 2).
Summary Measures of Risk
We next calculated a summary risk score comprised of an
unweighted count of the 19 risk-associated alleles. The average
increment in risk per allele was generally similar in all populations,
except Japanese Americans, where the effect of each allele was nearly
double that observed in Europeans ((odds ratio, 95% confidence
interval): African Americans, 1.09, 1.05–1.12; (P=3.0610
26);Native
Hawaiians, 1.10, 1.06–1.15 (P=1.2610
25); European Americans,
1.11, 1.06–1.17 (P=1.2610
25); Latinos, 1.12, 1.09–1.14 (P=
7.5610
219); and, Japanese, 1.20, 1.17–1.24; (P=7.0610
232);
Phet=3.8 610
24). Results were similar when limiting the analysis to
individuals with complete genotype data for all variants and when
including only those markers associated with risk (at P,0.10) (Table
S5). Individuals in the top quartile of the risk allele distribution were
at 1.6 (African Americans, P=5.3610
24)t o3 . 1 - f o l d( J a p a n e s e
Americans,P=7.9610
226)greater risk of diabetescompared tothose
in the lowest quartile (Table 3).
Figure 1. Risk allele frequencies by racial/ethnic group. Risk allele frequencies for each variant in European Americans (Blue), African
Americans (Yellow), Latinos (Purple), Japanese Americans (Red), and Native Hawaiians (Green). The order of the variants is based on the frequency of
the risk allele in European Americans (high to low).
doi:10.1371/journal.pgen.1001078.g001
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PLoS Genetics | www.plosgenetics.org 4 August 2010 | Volume 6 | Issue 8 | e1001078Using these ethnic-specific per allele odds ratio estimates and
the aggregate risk allele counts, we built a quantitative risk model
to compare the distribution of genetic risks between populations
associated with these marker alleles. The higher average number
of risk alleles in African Americans caused their distribution to be
slightly right shifted (towards higher log ORs) compared to
European Americans, however their relatively smaller per allele
odds ratio resulted in wide overlap with the European American
distribution (Figure 2). The Japanese Americans had a wider
distribution of risk because of the large per allele odds ratio, but
the low average risk allele counts caused the Japanese distribution
to be left-shifted (towards lower log ORs) compared to European
Americans. The distributions for Latinos and Native Hawaiians
were very similar to the European Americans.
Discussion
We tested 19 common genetic risk markers that were discovered
in European populations. We found that association with all 19 of
these SNPs trended in the same direction in this large multiethnic
study, and the majority of these variants were nominally significant
in their association with diabetes risk. A risk score comprised of
these alleles was significantly associated with diabetes risk in all five
racial/ethnic groups, with the only significant heterogeneity being
larger effect sizes in Japanese Americans. However, in comparing
the distribution of risk conferred by these alleles between
populations we found that they explain little, if any, of known
differences in the prevalence of diabetes between these popula-
tions.
These observations indicate that most, if not all, of these alleles
show directionally similar association to T2D across many
populations. Such a pattern indicates that the causal alleles at
these validated risk loci (which have yet to be found) likely predate
the migrations that separated these populations now residing in
Europe, Africa, East Asia, the Pacific Islands and the Americas.
We note that this pattern is unexpected under the recently
described ‘‘common SNP, rare mutation’’ model of Goldstein that
suggests that GWAS signals with common alleles for T2D and
other diseases may be ‘‘synthetic associations’’ created by one or
more rare alleles [19–21]. Under the Goldstein Hypothesis the
consistent associations that we noted at these loci across
populations would only be observed if, in each population, one
or more distinct rare alleles arose at each locus, and they happened
to arise each time on the same haplotype background. Although
possible, this scenario seems unlikely, and a more parsimonious
explanation would be the ‘‘synthetic association’’ hypothesis of
Goldstein does not apply to a majority of these T2D SNPs.
The modest number of cases and controls in this study (as
compared to the initial discovery studies) likely underlies the lack
of statistically significant associations in some groups. Weaker
associations in some racial/ethnic groups may also be due to
differences in allele frequencies, linkage disequilibrium, and
environmental and genetic modifiers. In two cases (WFS1 and
CDKAL1), significant heterogeneity by race/ethnicity reflected a
lack of association in African Americans, perhaps because of lower
linkage disequilibrium between the marker and the biologically
relevant allele.
It is interesting that the odds ratios observed for these marker
SNPs were larger in Japanese Americans than in the original
discovery cohorts, and in the other ethnic groups in our study. A
meta-analysis of 7 association studies in Japanese populations
replicated associations from studies in European populations for 7
loci under study (TCF7L2, CDKAL1, CDKN2B, IGF2BP2,
SLC30A8, KCNJ11, and HHEX) [24]. A recent GWAS in Japanese
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PLoS Genetics | www.plosgenetics.org 5 August 2010 | Volume 6 | Issue 8 | e1001078observed significant associations in KCNQ1 as well as these same 7
loci and, similar to our observations, noted magnitudes of effect
that were generally stronger than previously observed in European
populations [25]. Additional studies in other Asian populations
have replicated associations with many of these loci as well
[24,26–28].
In the Multiethnic Cohort, we have found the prevalence of
T2D to be at least 2-fold higher in African Americans, Latinos,
Japanese and Native Hawaiians compared to European Ameri-
cans, with these differences being independent of body weight
[14]. We examined the extent to which the known genetic risk
alleles for diabetes could explain these disparities by quantifying
and comparing the relative risk distributions between populations.
Compared to European Americans, we did not observe evidence
of greater genetic risk in any population. Our findings therefore
indicate that these risk markers explain little, if any, of racial/
ethnic disparities in T2D prevalence. It remains possible that the
actual causal alleles in these regions may be more common in
frequency and/or have larger effects than the index signals in non-
European populations. As seen with KCNQ1 [1,2], GWAS in non-
European populations are effective in discovering risk loci that are
important in multiple populations but difficult to identify in
European populations where the alleles are rare.
This study had a number of limitations. First, a self-report of
diabetes and use of medication for diabetes was used to define
cases and controls. We observed that approximately 1% of a
random sample of the controls in this study had HbA1C levels
above 7.0%, which suggests that only a small portion of controls
had undiagnosed diabetes (see Materials and Methods). Also, our
case definition did not differentiate between T1D and T2D,
however we expect this misclassification to be minor as ,3% of
T2D cases had a previous diagnosis of T1D based on other sources
(see Materials and Methods). The highly consistent findings of this
study, as compared to the discovery GWAS reports, argue that our
phenotypic characterization is adequate to observe the association
to T2D.
Some caution should also be given to the interpretation of the
risk modeling conducted in each ethnic group, as the genetic
markers included are unlikely to be the causal alleles. Future fine-
mapping and sequencing studies to identify the functional variants
(common and/or rare) and large-scale testing of each allele will be
required to more precisely model risk as well as assess differences
in the distribution of genetic risk across populations.
Another limitation is that we did not account for the potential
confounding effects of population stratification. However, odds
ratios were essentially unchanged after adjusting for global
European ancestry in a subset of African Americans (336 cases
397 controls) for whom ancestry markers were available,
suggesting that effects due to population substructure were not
substantial, at least in this group. We also noted that controlling
for education, a proxy for SES which has been shown to be
significantly associated with Native American ancestry in Latinos
[23], had little effect on the associations with these risk alleles.
Furthermore, the risk alleles were not generally more frequent in
Latinos than in European Americans which would be likely if these
alleles were proxies for more general ancestry differences. While
population stratification is unlikely to fully explain these findings, it
remains possible that at some loci, the causal alleles may be more
correlated with ancestry than the index SNPs.
In summary, our data provide strong support for common
genetic variation contributing to T2D risk in multiple populations.
Our findings in T2D do not support the theory that GWAS signals
Table 3. The association of the total risk score with T2D risk by racial/ethnic population.
a
European
Americans African Americans Latinos
Japanese
Americans Native Hawaiians Pooled
Total Risk alleles, Mean (range) 18.8 (10–27) 20.2 (11–27) 18.6 (10–28) 17.2 (10–26) 18.1 (10–26) 18.5 (10–28)
Per allele additive model
n (cases/controls) 533/1,006 1,077/1,469 2,220/2,184 1,736/1,761 576/983 6,142/7,403
OR(95% CI)
bc 1.11 (1.06–1.17) 1.09 (1.05–1.12) 1.12 (1.09–1.14) 1.20 (1.17–1.24) 1.10 (1.06–1.15) 1.13 (1.11–1.15)
P-value 1.2610
25 3.0610
26 7.5610
219 7.0610
232 1.2610
25 4.7610
259
P-value vs. European Americans Ref. 0.43 0.76 0.007 0.86
Quartiles of Risk Alleles
d
Q1 n (cases/controls) 69/196 206/360 362/464 267/441 119/251 1,023/1,712
OR(95% CI) 1.00(ref) 1.00(ref) 1.00(ref) 1.00(ref) 1.00(ref) 1.00(ref)
Q2 n (cases/controls) 112/273 273/437 520/605 424/518 150/307 1,479/2,140
OR(95% CI) 1.17 (0.79–1.73) 1.10 (0.86–1.40) 1.17 (0.97–1.42) 1.39 (1.12–1.72) 1.11 (0.81–1.52) 1.21 (1.08–1.35)
P-value 0.44 0.45 0.10 3.2610
23 0.51 8.4610
24
Q3 n (cases/controls) 170/281 353/391 626/587 297/306 167/259 1,613/1,824
OR(95% CI) 1.52 (1.05–2.21) 1.59 (1.25–2.01) 1.50 (1.25–1.81) 1.85 (1.46–2.36) 1.39 (1.02–1.90) 1.61 (1.44–1.80)
P-value 0.027 1.3610
24 2.1610
25 5.4610
27 0.039 4..2610
217
Q4 n (cases/controls) 182/256 245/281 712/528 748/496 140/166 2,027/1,727
OR(95% CI) 1.88 (1.29–2.74) 1.58 (1.22–2.04) 1.99 (1.65–2.40) 3.06 (2.48–3.77) 2.09 (1.49–2.94) 2.17 (1.95–2.42)
P-value 9.3610
24 5.3610
24 7.6610
213 7.9610
226 2.0610
25 4.6610
244
aOdds ratios (and 95% confidence intervals) adjusted for age (quartiles), BMI (quartiles), sex, and ethnicity (in pooled analysis).
bP=3.8 610
24 for heterogeneity of allelic effects across ethnic groups (4 df test).
cP#0.02 for each ethnic group for the comparison with Japanese Americans.
dQuartiles are defined separately for each population.
doi:10.1371/journal.pgen.1001078.t003
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PLoS Genetics | www.plosgenetics.org 6 August 2010 | Volume 6 | Issue 8 | e1001078are due to rare alleles. Nonetheless, GWAS and sequencing studies
in these and other racial/ethnic populations are needed to reveal a
more complete spectrum of risk alleles that are important globally
as well as those that may contribute to risk disparities.
Materials and Methods
Ethics Statement
The Institutional Review Boards at the University of Southern
California and University of Hawaii approved the study protocol.
Study Population
The MEC consists of 215,251 men and women, and comprises
mainly five self-reported racial/ethnic populations: European
Americans, African Americans, Latinos, Japanese Americans and
Native Hawaiians [29]. Between 1993 and 1996, adults between
45 and 75 years old were enrolled by completing a 26-page, self-
administered questionnaire asking detailed information about
dietary habits, demographic factors, level of education, personal
behaviors, and history of prior medical conditions (e.g. diabetes).
Potential cohort members were identified through Department of
Motor Vehicles drivers’ license files, voter registration files and
Health Care Financing Administration data files. In 2001, a short
follow-up questionnaire was sent to update information on dietary
habits, as well as to obtain information about new diagnoses of
medical conditions since recruitment. Between 2003 and 2007, we
re-administered a modified version of the baseline questionnaire.
All questionnaires inquired about history of diabetes, without
specification as to type (1 vs. 2). Between 1995 and 2004, blood
specimens were collected from ,67,000 MEC participants at
which time a short questionnaire was administered to update
certain exposures, and collect current information about medica-
tion use.
Cohort members in California are linked each year to the
California Office of Statewide Health Planning and Development
(OSHPD) hospitalization discharge database which consists of
mandatory records of all in-patient hospitalizations at most acute-
care facilities in California. Records include information on the
principal diagnosis plus up to 24 other diagnoses (coded according
to ICD-9), including T1D and T2D. In Hawaii cohort members
have been linked with the diabetes care registries for subjects with
Hawaii Medical Service Association (HMSA) and Kaiser Perma-
nente Hawaii (KPH) health plans (,90% of the Hawaiian
population has one of these two plans) [15]. Information from
these additional databases have been utilized to assess the
percentage of T2D controls (as defined below) with undiagnosed
T2D, as well as the percentage of identified diabetes cases with
T1D rather than T2D. Based on the OSHPD database ,3% of
Figure 2. Predicted distribution of T2D risk from common variants by racial/ethnic group compared to European Americans.
Comparison of the predicted risk distributions conveyed by the risk alleles relative to European Americans (Blue in Panels A–D): Panel A, African
Americans (Red); Panel B, Latinos (Yellow); Panel C, Japanese Americans (Brown); Panel D, Native Hawaiians (Green). The x-axis is the log relative risk
for each population centered (at log RR=0) around the average total risk allele count in the multiethnic sample (18.5). The y-axis is the relative
frequency of the population with that level of risk.
doi:10.1371/journal.pgen.1001078.g002
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PLoS Genetics | www.plosgenetics.org 7 August 2010 | Volume 6 | Issue 8 | e1001078T2D cases had a previous diagnosis of T1D. We did not use these
sources to identify T2D cases because they did not include
information on diabetes medications, one of our inclusion criteria
for cases (see below).
In this study, diabetic cases were defined using the following
criteria: (a) a self-report of diabetes on the baseline questionnaire,
2
nd questionnaire or 3
rd questionnaire; and (b) self-report of taking
medication for T2D at the time of blood draw; and (c) no diagnosis
of T1D in the absence of a T2D diagnosis from the OSHPD
(California Residents). Controls were defined as: (a) no self-report
of diabetes on any of the questionnaires while having completed a
minimum of 2 of the 3 (79% of controls returned all 3
questionnaires); and (b) no use of medications for T2D at the
time of blood draw; and (c) no diabetes diagnosis (type 1 or 2) from
the OSHPD, HMSA or KPH registries. To preserve DNA for
genetic studies of cancer in the MEC, subjects with an incident
cancer diagnosis at time of selection for this study were excluded.
Controls were frequency matched to cases on age at entry into the
cohort (5-year age groups) and for Latinos, place of birth (U.S. vs.
Mexico, South or Central America), oversampling African
American, Native Hawaiian and European American controls to
increase statistical power.
Fasting glucose (FG) and HbA1C measurements were used to
validate the case-control selection criteria. Among 185 T2D cases
and 1,048 controls who met the T2D case-control definitions
above and with FG measurements available from ongoing studies
in the MEC, 57% of cases (ranging from 43% in European
Americans to 63% in Japanese Americans) and 3% of controls
(ranging from 1% in African Americans to 6% in Latinos) had a
FG value .125 mg/dl. We also measured HbA1C (ARUP
Laboratories, Salt Lake City, Utah) in 50 cases and 50 controls
per each sex-ethnic group. Just over 1% (6/500) of controls were
likely to have unreported T2D (HbA1C value $7%). In contrast,
,47% (234/500) of T2D cases had HbA1C $7% (ranging from
41% in European Americans to 57% of Native Hawaiians). Since
hypoglycemic medication use was part of the case selection
criteria, some cases were expected to have FG and HbA1C levels in
the normal range.
Altogether, this study included 6,142 T2D cases and 7,403
controls (European American (533/1,006), African American
(1,077/1,469), Latino (2,220/2,184), Japanese American (1,736/
1,761) and Native Hawaiian (576/983)). Genotyping was con-
ducted by the TaqMan allelic discrimination assay (Applied
Biosystems, Foster City, CA) [30]. For all SNPs, genotype call
rates were .95% among case and control groups in each
population and HWE p-values among controls were .0.05 in at
least 4 of the 5 ethnic groups and none of the values were ,0.01
(Table S6). Subjects missing data for .5 SNPs (n=82) were
removed from the analysis.
Statistical Analysis
Odds ratios and 95% confidence intervals were calculated for
each allele in unconditional logistic regression models while
adjusting for age at cohort entry (quartiles), body mass index (BMI,
kg/m
2, quartiles), sex, and race/ethnicity (pooled analysis) in
ethnic-stratified and pooled analyses. Associations with the two
variants at KCNQ1 were examined adjusting for the other allele.
Potential confounding factors including, smoking history, educa-
tion, physical activity, and history of hypertension were evaluated
but did not influence the results. Potential confounding by percent
European ancestry was examined in a subset of African American
men (336 cases, 397 controls) with available genetic ancestry
information [16,31,32].
We also modeled the cumulative genetic risk of T2D using these
markers. We summed the number of risk alleles for each individual
and estimated the odds ratio per allele for this aggregate
unweighted allele count variable as an approximate risk score
appropriate for unlinked variants with independent effects of
approximately the same magnitude for each allele. We also
examined a second model where each allele was weighted and
multiplied by the log of the published odds ratio prior to summing
all alleles. The results of the more parsimonious unweighted risk
score is presented as the two risk scores were highly correlated in
each ethnic group (Pearson r$0.92) and similar associations with
T2D risk were observed for each score. For individuals missing
genotypes for a given SNP, we assigned the average number of risk
alleles within each ethnic group (26 risk allele frequency) to
replace the missing value for that SNP. We used these ethnic-
specific per allele summary odds ratios and the total number of risk
alleles among control subjects to estimate the distribution of
relative risks conveyed by all risk alleles. To avoid making the
reference group carriers of zero risk alleles (a group which does not
exist) we centered the distribution on the mean number of risk
alleles observed in the control population (18.5). The log relative
risk for each subject was calculated as logRR=(RA218.5)6lo-
g(ORi) (where RA is equal to the subject’s total risk alleles and
log(ORi) is the log of the ethnic specific per allele odds ratio. A
spline function was used to capture the shape of the distributions of
log OR for display purposes. Two variants in KCNQ1 were
included in the risk modeling because both were significantly
associated with T2D when co-modeled (results were similar when
only the most significant of the two, rs2237897, was included). The
variant in FTO was excluded from risk modeling procedures, as
we found (as have others) that it is not a risk factor for diabetes
independent of its effect on obesity.
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